Which genetic mutations are associated with a slow catechol-O-methyltransferase (COMT) activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Slow COMT Genetic Mutations

The Met/Met genotype (homozygous for the Met allele) at the Val158Met polymorphism (rs4680, G472A) produces slow COMT enzyme activity.

Primary Mutation Associated with Slow COMT Activity

The Val158Met polymorphism (rs4680, also designated as G472A or c.472G>A) is the most well-established genetic variant associated with slow COMT activity 1. This single nucleotide polymorphism results in:

  • Met/Met homozygotes: Produce low-activity COMT enzyme with approximately 40% decreased activity compared to wild-type 2
  • Met carriers (Met/Met and Val/Met): Demonstrate reduced enzymatic function, with Met/Met showing the most pronounced effect 1
  • Mechanism: The Met108 variant allozyme displays a 70-90% decrease in immunoreactive protein levels compared to wild-type, explaining the reduced enzymatic activity 2

COMT Haplotype System

Beyond the single Val158Met polymorphism, COMT activity is determined by haplotype combinations involving multiple SNPs 3, 4:

Three Main Haplotypes

  • Low Pain Sensitivity (LPS) haplotype: Associated with high COMT activity 3
  • Average Pain Sensitivity (APS) haplotype: Produces 3-fold reduction in COMT enzymatic activity 3
  • High Pain Sensitivity (HPS) haplotype: Produces 20-fold reduction in COMT enzymatic activity 3

Key SNPs Defining Haplotypes

The haplotypes are determined by four primary SNPs 3, 4:

  • rs6269: Located in the 5' regulatory region; this SNP appears to be the primary determinant of the low pain sensitivity haplotype 4
  • rs4633: Synonymous variant linked to haplotype determination 3
  • rs4818 (c.408C>G): Associated with varying S-COMT protein levels 5
  • rs4680 (Val158Met): The functional nonsynonymous variant 3

The low-activity variants are primarily determined by the Met allele at rs4680 and specific alleles at rs6269 4.

Additional Variants

Minor SNPs that are linked to low-activity haplotypes but do not independently modify COMT function include 3:

  • rs769224: Synonymous SNP linked to APS haplotype (1-5% population frequency) 3
  • rs6267: Synonymous SNP linked to HPS haplotype 3
  • rs740602: Synonymous SNP linked to HPS haplotype 3
  • rs8192488: Nonsynonymous SNP linked to HPS haplotype 3

These minor variants serve as markers rather than independent functional contributors to COMT activity 3.

Clinical Significance of Slow COMT

Individuals with slow COMT variants demonstrate 1, 6:

  • Increased risk of postpartum depression: Met/Met genotype associated with 30% of variance in PPD when combined with other factors 1
  • Cognitive vulnerability: Val allele (paradoxically associated with lower cortical dopamine) linked to cognitive impairment after cancer treatment 6
  • Rapid cycling bipolar disorder: Low-activity Met allele frequency of 0.55 in rapid cyclers versus 0.42 in non-rapid cyclers 7
  • Chronic pain susceptibility: Low-activity variants associated with increased pain sensitivity and chronic persistent surgical pain 8

Protein-Level Effects

Soluble COMT (S-COMT) but not membrane-bound COMT (MB-COMT) levels vary by genotype 5:

  • Genotypes at rs4680 and rs4818 are associated with differing S-COMT protein levels 5
  • rs737865 and rs165599 show no association with COMT protein levels 5
  • The Met108 allozyme shows enhanced proteolysis, explaining reduced protein levels 2

Ethnic Variation

COMT variant frequencies differ substantially across populations 9, 4:

  • TPMT*3C (related methyltransferase): 2-3.2% frequency in Chinese populations versus ~5% TPMT*3A in Caucasians 9
  • Low pain sensitivity haplotype: Varies from 13% to 44% across 13 global populations 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.